News About: Pharm. Industry
A world level of bio new drug R&D center in Daedeok Research Cluster.
The Korea Institute of Toxicology (KIT) and an American bio pharmaceutical company, ISIS, planned to establish "KIT-ISIS Bio New Drug R&D Center" in attendance of Daedeok Innopolice for a successful development of bio...
Pharmaceutical stocks to draw growing buy interest
Despite the prevailing view that Korean companies can no longer expect success only by depending on making generic drugs in an era of the Korea-U.S. FTA, pharmaceutical stocks of major drug makers will increase gains,...
SK Chemical and MSD Korea in strategic alliance for vaccines.SK Chemical announced on April 9 that the company made a strategic alliance with MSD Korea for the distribution of Gardasil, a first cervical cancer vaccine and Rotateq, an anti...
|
Diabetic patients can apply to Bayer Dream Fund until May 31
Bayer HealthCare said that until May 31, its 2007 Bayer Dream Fund will be open to anyone with diabetes or his/his family meeting the eligible criteria, who has a special dream that would not have been possible unless...
FTA threatens Korea to leap up for new drug R&D
The KPMA sensitively worries that the guarantee of patent issues under the KORUS FTA agreement might cause local drug industries to lose a leap-up chance for lifting Korea to the nations of new drug development.
...
Generic giants to get easier access to Korean pharmaceutical market
The Korea-U.S. free trade agreement is expected to make it easier for foreign generic giants, Ranbaxy Laboratories Limited, to open businesses in the domestic pharmaceutical market.
Ranbaxy is India's largest pharm...
Drug makers to adopt holding company system
Choong-wae Pharm has stepped up its restructuring efforts to adopt a holding company system for securing its managerial right and maintaining a corporate spirit, as the domestic pharmaceutical sector is expected to fa...
FTA to give adverse impact to wholesaler's profitability.
The drug industry as well as wholesalers have faced with a big business damage especially over generic drugs under the FTA far beyond their earlier expectation when it's reality was surfaced.
The local drug wholesa...
Big wholesalers' influence up
Large drug wholesalers with sales grater than 200 billion won saw their combined market share continue to increase steadily in 2006, exerting influence on the overall wholesaling industry.
According to the tallie...
KFDA announces voluntary withdrawal of Zelmac
The Korea Food and Drug Administration (KFDA) announced on April 2 that Novartis Korea has halted sales of Zelmac (tegaserod), its agent for irritable bowel syndrome and constipation, following suggestions of a small ...
